Phone
+61 (0)2 9385 0900
E-mail
akwon@kirby.unsw.edu.au
Location
Wallace Wurth Building, UNSW
Kwon JA; Bretaña NA; Kronfli N; Dussault C; Grant L; Galouzis J; Hoey W; Blogg J; Lloyd AR; Gray RT, 2024, 'Preparing correctional settings for the next pandemic: a modeling study of COVID-19 outbreaks in two high-income countries', Frontiers in Public Health, 12, http://dx.doi.org/10.3389/fpubh.2024.1279572
2024
Shih STF; Stone J; Martin NK; Hajarizadeh B; Cunningham EB; Kwon JA; McGrath C; Grant L; Grebely J; Dore GJ; Lloyd AR; Vickerman P; Chambers GM, 2024, 'Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofad637
2024
Shih STF; Cheng Q; Carson J; Valerio H; Sheehan Y; Gray RT; Cunningham EB; Kwon JA; Lloyd AR; Dore GJ; Wiseman V; Grebely J, 2023, 'Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis', The Lancet Regional Health - Western Pacific, 36, http://dx.doi.org/10.1016/j.lanwpc.2023.100750
2023
Cheng Q; Hoad VC; Roy Choudhury A; Seed CR; Bentley P; Shih STF; Kwon JA; Gray RT; Wiseman V, 2023, 'Removing hepatitis C antibody testing for Australian blood donations: A cost-effectiveness analysis', Vox Sanguinis, 118, pp. 471 - 479, http://dx.doi.org/10.1111/vox.13429
2023
Razavi-Shearer D; Gamkrelidze I; Pan C; Jia J; Berg T; Gray R; Lim YS; Chen CJ; Ocama P; Desalegn H; Abbas Z; Abdallah A; Aghemo A; Ahmadbekova S; Ahn SH; Aho I; Akarca U; Al Masri N; Alalwan A; Alavian S; Al-Busafi S; Aleman S; Alfaleh F; Alghamdi A; Al-Hamoudi W; Aljumah A; Al-Naamani K; Al-Rifai A; Alserkal Y; Altraif I; Amarsanaa J; Anderson M; Andersson M; Armstrong P; Asselah T; Athanasakis K; Baatarkhuu O; Ben-Ari Z; Bensalem A; Bessone F; Biondi M; Bizri AR; Blach S; Braga W; Brandão-Mello C; Brosgart C; Brown K; Brown, R; Bruggmann P; Brunetto M; Buti M; Cabezas J; Casanovas T; Chae C; Chan HLY; Cheinquer H; Chen PJ; Cheng KJ; Cheon ME; Chien CH; Choudhuri G; Christensen PB; Chuang WL; Chulanov V; Cisneros L; Coffin C; Contreras F; Coppola N; Cornberg M; Cowie B; Cramp M; Craxi A; Crespo J; Cui F; Cunningham C; Dalgard O; De Knegt R; De Ledinghen V; Dore G; Drazilova S; Duberg AS; Egeonu S; Elbadri M; El-Kassas M; El-Sayed M; Estes C; Etzion O; Farag E; Ferradini L; Ferreira P; Flisiak R; Forns X; Frankova S; Fung J; Gane E; Garcia V; García-Samaniego J; Gemilyan M; Genov J; Gheorghe L, 2023, 'Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study', The Lancet Gastroenterology and Hepatology, 8, pp. 879 - 907, http://dx.doi.org/10.1016/S2468-1253(23)00197-8
2023
Blach S; Terrault NA; Tacke F; Gamkrelidze I; Craxi A; Tanaka J; Waked I; Dore GJ; Abbas Z; Abdallah AR; Abdulla M; Aghemo A; Aho I; Akarca US; Alalwan AM; Alanko Blomé M; Al-Busafi SA; Aleman S; Alghamdi AS; Al-Hamoudi WK; Aljumah AA; Al-Naamani K; Al Serkal YM; Altraif IH; Anand AC; Anderson M; Andersson MI; Athanasakis K; Baatarkhuu O; Bakieva SR; Ben-Ari Z; Bessone F; Biondi MJ; Bizri ARN; Brandão-Mello CE; Brigida K; Brown KA; Brown, RS; Bruggmann P; Brunetto MR; Busschots D; Buti M; Butsashvili M; Cabezas J; Chae C; Chaloska Ivanova V; Chan HLY; Cheinquer H; Cheng KJ; Cheon ME; Chien CH; Chien RN; Choudhuri G; Christensen PB; Chuang WL; Chulanov V; Cisneros LE; Coco B; Contreras FA; Cornberg M; Cramp ME; Crespo J; Cui F; Cunningham CW; Dagher Abou L; Dalgard O; Dao DY; De Ledinghen V; Derbala MF; Deuba K; Dhindsa K; Djauzi S; Drazilova S; Duberg AS; Elbadri M; El-Sayed MH; Esmat G; Estes C; Ezzat S; Färkkilä MA; Ferradini L; Ferraz MLG; Ferreira PRA; Filipec Kanizaj T; Flisiak R; Frankova S; Fung J; Gamkrelidze A; Gane E; Garcia V; García-Samaniego J; Gemilyan M; Genov J; Gheorghe LS; Gholam PM; Goldis A; Gottfredsson M; Gray RT; Grebely J; Gschwantler M, 2022, 'Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study', The Lancet Gastroenterology and Hepatology, 7, pp. 396 - 415, http://dx.doi.org/10.1016/S2468-1253(21)00472-6
2022
Lim M; Devine A; Gray RT; Kwon JA; Hutchinson JL; Ong JJ, 2022, 'Lifetime cost of HIV management in Australia: an economic model', Sexual Health, 19, http://dx.doi.org/10.1071/SH21250
2022
Kwon JA; Chambers GM; Luciani F; Zhang L; Kinathil S; Kim D; Thein HH; Botha W; Thompson S; Lloyd A; Yap L; Gray RT; Butler T, 2021, 'Hepatitis C treatment strategies in prisons: A cost-effectiveness analysis', PLoS ONE, 16, pp. e0245896, http://dx.doi.org/10.1371/journal.pone.0245896
2021
Kwon JA; Dore GJ; Hajarizadeh B; Alavi M; Valerio H; Grebely J; Guy R; Gray RT, 2021, 'Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications', PLoS ONE, 16, http://dx.doi.org/10.1371/journal.pone.0257369
2021
Binka M; Janjua NZ; Grebely J; Estes C; Schanzer D; Kwon JA; Shoukry NH; Kwong JC; Razavi H; Feld JJ; Krajden M, 2020, 'Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated Model', JAMA Network Open, 3, http://dx.doi.org/10.1001/jamanetworkopen.2020.4192
2020
Kwon JA; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Power C; Estes C; Razavi H; Gray RT; Dunlop A; Zekry A; Lloyd A; Duvnjak A; Treloar C; Tyrrell H; George J; Iversen J; Marriott K; Crooks L; Maher L; Douglas M, 2019, 'Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study', Journal of Viral Hepatitis, 26, pp. 83 - 92, http://dx.doi.org/10.1111/jvh.13013
2019
Kwon JA; Iversen J; Law M; Dolan K; Wand H; Maher L; Han A, 2019, 'Estimating the number of people who inject drugs and syringe coverage in Australia, 2005–2016', Drug and Alcohol Dependence, 197, pp. 108 - 114, http://dx.doi.org/10.1016/j.drugalcdep.2018.11.033
2019
Kwon J; Anderson JS; Kerr CC; Thein H; Zhang L; Iversen J; Dore GJ; Kaldor JM; Law MG; Maher L; Wilson DP; Han A, 2012, 'Estimating the cost-effectiveness of needle-syringe programs in Australia.', AIDS, 26, pp. 2201 - 2210, http://dx.doi.org/10.1097/QAD.0b013e3283578b5d
2012
Kwon J; Iversen J; Maher L; Law M; Wilson D, 2009, 'The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: A model-based analysis', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 51, pp. 462 - 469, http://dx.doi.org/10.1097/QAI.0b013e3181a2539a
2009
Gray RT; Heymer K; Hoare A; Kwon JA; Thein H; Lote N; Siba P; Saramony S; Saphonn V; Worth H; Kaldor JM; Wilson DP, 2009, 'What impact might the economic crisis have on HIV epidemics in Southeast Asia?', Current HIV Research, 7, pp. 656 - 665, http://dx.doi.org/10.2174/157016209789973637
2009
Kwon JA; Bretaña NA; Kronfli N; Dussault C; Grant L; Galouzis J; Hoey W; Blogg J; Lloyd AR; Gray RT, 2023, Preparing correctional settings for the next pandemic: a modelling study of COVID-19 outbreaks in two high-income countries, , http://dx.doi.org/10.1101/2023.05.08.23289690
2023
Wu H-J; Shih STF; Applegate TL; Kwon J; Cunningham EB; Grebely J; Gray RT, 2023, Impact of Simplified HCV Diagnostic Strategies on the HCV Epidemic Among Men Who Have Sex with Men in Taiwan: A Modelling Study, , http://dx.doi.org/10.2139/ssrn.4431789
2023
Shih STF; Cheng Q; Carson J; Valerio H; Sheehan Y; Gray RT; Cunningham EB; Kwon J; Lloyd AR; Dore GJ; Wiseman V; Grebely J, Optimizing Point-of-Care Testing Strategies for Diagnosis and Treatment of Hepatitis C Virus Infection in Australia: A Model-Based Cost-Effectiveness Analysis, , http://dx.doi.org/10.2139/ssrn.4267527
Lim M; Devine A; Gray RT; Kwon J; Hutchinson J; Ong J, Lifetime Cost of HIV Management in Australia: An Economic Model, , http://dx.doi.org/10.2139/ssrn.3868096
Shih STF; Cheng Q; Carson J; Valerio H; Sheehan Y; Gray RT; Cunningham EB; Kwon J; Lloyd AR; Dore GJ; Wiseman V; Grebely J, Optimizing Point-of-Care Testing Strategies for Diagnosis and Treatment of Hepatitis C Virus Infection in Australia: A Model-Based Cost-Effectiveness Analysis, , http://dx.doi.org/10.2139/ssrn.4267510
Kwon J; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Power C; Estes C; Razavi H; Gray RT, Australia on Track to Achieve Who HCV Elimination Targets Following Rapid Initial DAA Treatment Uptake: A Modelling Study, , http://dx.doi.org/10.2139/ssrn.3213670
King J; McManus H; Kwon J; Gray R; McGregor S, 2023, HIV, viral hepatitis and sexually transmissible infections in Australia: Annual surveillance report 2023, Kirby Institute, UNSW Sydney, Sydney, UNSW, http://dx.doi.org/10.26190/f5ph-f972
2023
Heard S; Zolala F; Kwon A; Maher L, 2023, Needle Syringe Program National Minimum Data Collection: National Data Report 2023, http://dx.doi.org/10.26190/9kav-de21, https://www.kirby.unsw.edu.au/research/reports/needle-syringe-program-national-minimum-data-collection-2023-national-data-report
2023
Heard S; Iversen J; Geddes L; Kwon A; Maher L, 2022, Needle Syringe Program National Minimum Data Collection: National Data Report 2022, http://dx.doi.org/10.26190/y3nf-2x07, https://www.kirby.unsw.edu.au/research/reports/needle-syringe-program-national-minimum-data-collection-2022-national-data-report
2022
King J; McManus H; Kwon J; Gray R; McGregor S, 2022, HIV, viral hepatitis and sexually transmissible infections in Australia: Annual surveillance report 2022, The Kirby Institute, UNSW Sydney, Sydney, Australia, http://dx.doi.org/10.26190/sx44-5366, https://kirby.unsw.edu.au/report/asr2022
2022
Bajis S; Dore G; Alavi M; McGregor S; Kwon A; Monaghan R; Iversen J; Martinello M; Buckland G; Guy R; Kaldor J; Grebely J, 2021, Progress towards hepatitis C elimination among Aboriginal and Torres Strait Islander people in Australia: monitoring and evaluation report, The Kirby Institute, UNSW Sydney, Sydney, Australia, https://kirby.unsw.edu.au/report/progress-towards-hepatitis-c-elimination-among-aboriginal-and-torres-strait-islander-people
2021
Heard S; Iversen J; Geddes L; Kwon A; Maher L, 2021, Needle Syringe Program National Minimum Data Collection: National Data Report 2021, http://dx.doi.org/10.26190/3cg0-jd64, https://www.kirby.unsw.edu.au/research/reports/needle-syringe-program-national-minimum-data-collection-2021-national-data-report
2021
Heard S; Iversen J; Geddes L; Kwon A; Maher L, 2020, Needle Syringe Program National Minimum Data Collection: National Data Report 2020, http://dx.doi.org/10.26190/a9gr-tq33, https://www.kirby.unsw.edu.au/research/reports/needle-syringe-program-national-minimum-data-collection-report-2020
2020
Iversen J; Heard S; Maher L; Kwon A, 2019, Needle Syringe Program National Minimum Data Collection: National Data Report 2019, http://dx.doi.org/10.26190/cwdt-3t58, https://kirby.unsw.edu.au/report/needle-syringe-program-national-minimum-data-collection-report-2019
2019
Iversen J; Maher L; Heard S; Kwon A, 2018, Needle Syringe Program National Minimum Data Collection: National Data Report 2018, http://dx.doi.org/10.26190/gsrt-6r60
2018
Heard S; Iversen J; Kwon JA; Maher L, 2017, Needle Syringe Program National Minimum Data Collection: National Data Report 2017, http://dx.doi.org/10.26190/5t18-bm18
2017
Kwon J; Gray R; Dore G; Grebely J; Guy R; Hajarizadeh B; Cunningham E, 2017, 2017 Estimates and Projections of the Hepatitis C Virus Epidemic in NSW: Summary Report, Sydney: Kirby Institute, UNSW Sydney
2017
Iversen JL; Heard S; Kwon JA; Maher L, 2017, Needle Syringe Program National Minimum Data Collection: National Data Report 2016, http://dx.doi.org/10.26190/pfsv-q451
2017
Wilson DP; Zhang L; Loo V; Thein HH; Gray RT; Kwon AJ, 2011, Evaluation of the epidemiological impact of harm reduction programs on HIV in Vietnam, The National Centre in HIV Epidemiology and Clinical Research, UNSW, Sydney Australia
2011
Wilson DP; Kwon AJ; Kerr CC; Zhang L; Hoare A, 2010, HIV in Indonesia Model, The National HIV Centre in HIV Epidemiology and Clinical Research, UNSW, Sydney, Australia
2010
Wilson D; Kwon A; Anderson J; Thein H; Law M; Maher L; Dore G; Kaldor J, 2009, Return on investment 2: evaluating the cost-effectiveness of needle and syringe programs among injecting drug users in Australia, Publications Production Unit (Public Affairs, Parliamentary and Access Branch) Commonwealth Department of Health and Ageing, Canberra, Australia, 3123, http://www.nchecr.unsw.edu.au/nchecrweb.nsf/resources/Reports/$file/RO-2ReportLQ.pdf
2009
Wilson DP; Gray R; Heymer K; Hoare A; Kwon A; Thein H; Worth H; Kaldor JM; Heymer K, 2009, Evaluation of the potential impact of the global economic crisis on HIV epidemics in Southeast Asia (prepared for AusAID), National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
2009
Kwon J; Bretaña N; Grant L; Galouzis J; Hoey W; Blogg J; Lloyd A; Gray R, 2021, The COVID-19 Incarceration Model: a tool for corrections staff to analyze outbreaks of COVID-19, , http://dx.doi.org/10.1101/2021.02.18.21252032
2021
Lim MHA; Devine A; Gray RT; Kwon JA; Hutchinson JL; Ong JJ, 2021, 'LIFETIME COST OF HIV MANAGEMENT IN AUSTRALIA: A MODELLING STUDY', in SEXUAL HEALTH, CSIRO PUBLISHING, Vol. 18, pp. VIII - VIII, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693686000018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2021
Kwon JA; Dore G; Hajarizadeh B; Guy R; Gray RT, 2020, 'Evidence of declining HCV transmission in Australia following scale-up of direct acting antiviral therapy', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vol. 73, pp. S606 - S606, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000786587002012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2020
Kwon A; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Estes C; Homie R; Gray RT, 2018, 'Ongoing Burden of Advanced Liver Disease Complications Despite Rapid HCV Treatment Scale-Up', presented at Australasian Viral Hepatitis Conference, 13 August 2018 - 15 August 2018
2018
Kwon A; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Estes C; Razavi H; Gray RT, 2017, 'Australia Could Meet the WHO HCV Elimination Targets If the Current Rollout of DAA Treatment Is Continued', presented at Australasian Viral Hepatitis Conference (AVHC), 10 August 2017 - 11 August 2017
2017
Kwon AJ; Iversen J; Maher L; Law MG; Wilson DP, 2009, 'The impact of NSPs on HIV and HCV transmissions in IDUs in Australia: A model-based analysis', presented at International Workshop on Modelling and Data Analysis for Infectious Disease Control, Durras, NSW, Australia, 09 March 2009 - 12 March 2009
2009
Kwon AJ; Thein HH; Anderson J; Wilson DP, 2009, 'Is NSP preventing HIV and HCV epidemics among Australian IDUs?: The past and future analysis', presented at The Australasian HIV/ AIDS Conference, Brisbane, Australia, 07 September 2009 - 09 September 2009
2009
Kwon A; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham E; Estes C; Razavi H; Gray RT, 2018, 'Australia on track to achieve WHO elimination targets following rapid initial DAA treatment uptake', presented at International Liver Congress (European Association for the Study of the Liver (EASL 2018)), 11 April 2018 - 15 April 2018
2018

Modelling infectious disease, cost-effectiveness analysis